Michigan Cannabis Market Struggles: Oversupply, Closures, and Industry Challenges

Executive Summary

Michigan's cannabis market, once among the nation's most promising, faces severe contraction as oversupply, plummeting wholesale prices, and regulatory burdens force facility closures and mass layoffs across the state. In May 2026, a major cultivation facility in Lansing announced plans to close and lay off 95 workers, becoming the latest casualty in a market where wholesale flower prices have collapsed from $3,000 per pound in 2020 to under $500 per pound in 2026. The state's adult-use program, which launched in December 2019, initially attracted hundreds of license applicants and billions in investment capital. However, the rapid expansion of cultivation capacity—Michigan issued over 1,400 active licenses by early 2026—created a glut that has devastated profit margins for growers, processors, and vertically integrated operators alike. The crisis extends beyond individual businesses: it threatens tax revenue projections, employment in communities that welcomed cannabis as an economic development tool, and the viability of social equity programs designed to repair harms from prohibition. As Michigan grapples with market correction, the state's experience offers critical lessons for emerging cannabis markets nationwide about the dangers of unlimited licensing, the importance of demand forecasting, and the structural challenges of competing against illicit markets while bearing the full weight of state taxation and federal restrictions under 280E.

Why This Matters

The Michigan cannabis market collapse affects thousands of workers, hundreds of millions in capital investment, and the economic futures of municipalities that bet on cannabis tax revenue. The Lansing facility closure represents just one data point in a broader crisis. According to the Michigan Cannabis Regulatory Agency, the state had 1,437 active licenses as of April 2026, supporting an estimated 25,000 direct jobs in cultivation, processing, retail, and testing. Industry analysts estimate that between 15% and 25% of these positions face elimination as operators consolidate or exit the market entirely. Investors have poured approximately $2.3 billion into Michigan cannabis infrastructure since 2019, according to data compiled by cannabis investment tracker Viridian Capital Advisors. Much of this capital financed cultivation facilities built on the assumption of sustained wholesale prices above $1,500 per pound. With current prices hovering between $400 and $600 per pound for premium flower, many facilities cannot cover operating costs, let alone service debt or provide returns to equity holders. Municipalities face their own reckoning. Cities like Detroit, Lansing, and Ann Arbor incorporated cannabis tax revenue into budget projections, funding everything from road repairs to public safety initiatives. Detroit alone projected $10 million annually from its local cannabis excise tax. As businesses close and sales stagnate, these revenue streams are evaporating. The state collected $276 million in cannabis excise and sales taxes in fiscal year 2025, but projections for fiscal year 2026 have been revised downward by approximately 12% as market contraction accelerates. Patients in Michigan's medical program—which predates adult-use legalization and served approximately 350,000 registered patients as of 2025—face potential access issues as dispensaries close. While the state maintains 520 active provisioning centers, closures have been concentrated in rural areas where patient populations cannot support standalone medical-only facilities.

Background and History: From Medical Pioneer to Oversaturated Market

Michigan's journey from medical cannabis pioneer to market crisis spans nearly two decades of policy evolution, voter initiatives, and regulatory growing pains.

2008: Medical Marijuana Act Passes

Michigan voters approved the Michigan Medical Marihuana Act (MMMA) in November 2008 with 63% support, making Michigan the 13th state to legalize medical cannabis. The law, codified at MCL 333.26421 et seq., established a caregiver model allowing registered patients to designate individuals to cultivate up to 12 plants on their behalf. The law created no commercial licensing framework, no state-regulated dispensaries, and minimal oversight beyond patient and caregiver registration. This decentralized model persisted for eight years. By 2016, Michigan had approximately 218,000 registered medical cannabis patients but no legal commercial supply chain. Dispensaries operated in legal gray areas, claiming protection under the MMMA's patient-to-patient transfer provisions or local ordinances. Law enforcement and courts remained divided on whether these operations violated state law.

2016: Medical Marihuana Facilities Licensing Act

In September 2016, the Michigan Legislature passed the Medical Marihuana Facilities Licensing Act (MMFLA), signed by Governor Rick Snyder. The MMFLA, codified at MCL 333.27101 et seq., created five commercial license types: growers (Class A, B, and C based on plant count), processors, provisioning centers (dispensaries), secure transporters, and safety compliance facilities (testing labs). The law established the Bureau of Medical Marihuana Regulation within the Department of Licensing and Regulatory Affairs to issue licenses and enforce compliance. Critically, the MMFLA gave municipalities authority to opt in or out of allowing facilities and to impose local licensing requirements and fees on top of state regulations. The first MMFLA licenses were issued in December 2017. By November 2018, when voters approved adult-use legalization, Michigan had issued approximately 280 medical licenses, with the majority concentrated in Detroit, Ann Arbor, and other urban centers that opted in early.

2018: Adult-Use Legalization (Proposal 1)

On November 6, 2018, Michigan voters approved Proposal 1, the Michigan Regulation and Taxation of Marihuana Act (MRTMA), with 56% support. The MRTMA, codified at MCL 333.27951 et seq., legalized possession of up to 2.5 ounces of cannabis for adults 21 and older and authorized commercial cultivation, processing, and retail sales. The law imposed a 10% excise tax on retail sales (in addition to the state's 6% sales tax) and directed revenue to implementation costs, education, roads, and municipalities that host facilities. Like the MMFLA, the MRTMA preserved municipal opt-in authority, allowing cities and townships to prohibit commercial cannabis operations within their borders. The MRTMA required the state to begin accepting adult-use license applications by December 6, 2019. The renamed Marijuana Regulatory Agency (MRA), formerly the Bureau of Medical Marihuana Regulation, issued the first adult-use licenses in November 2019, with the first legal sales occurring on December 1, 2019.

2020-2021: Explosive Growth and Capital Influx

Michigan's adult-use market exploded in its first two years. Total cannabis sales (medical and adult-use combined) reached $1.4 billion in 2020 and $1.8 billion in 2021, according to MRA data. Wholesale flower prices remained robust through mid-2021, averaging $2,200 to $2,800 per pound for premium indoor flower. The MRA adopted an approach that favored market access over supply constraints. Unlike states such as Illinois, which capped licenses and required competitive scoring, Michigan implemented a first-come, first-served system for most license types, subject only to meeting regulatory requirements and securing municipal approval. By December 2021, the state had issued over 900 active licenses. Multi-state operators (MSOs) including Cresco Labs, Green Thumb Industries, and Verano Holdings entered Michigan through acquisitions and new builds. Regional operators expanded aggressively. Municipalities that initially opted out began opting in as neighboring communities captured tax revenue, creating a competitive dynamic that accelerated license issuance.

2022-2023: Oversupply Emerges

By early 2022, industry observers began warning of oversupply. The MRA had issued over 1,100 active licenses by mid-2022, including more than 400 cultivation facilities. Wholesale prices began declining in the second quarter of 2022, falling below $2,000 per pound by summer and continuing downward through year-end. Several factors drove the glut. Michigan's climate and real estate costs made it attractive for large-scale cultivation. The state imposed no canopy caps on Class C grower licenses, allowing facilities to cultivate up to 2,000 plants. Operators who secured licenses in 2020-2021 brought facilities online in 2022, flooding the market with flower just as consumer demand growth slowed. Retail prices remained relatively stable due to competitive pressure, but the margin compression hit cultivators hardest. By December 2022, wholesale prices for premium flower had fallen to $1,200 to $1,500 per pound, and mid-tier flower traded below $1,000 per pound. The MRA continued issuing licenses. By January 2023, Michigan had 1,287 active licenses, more than any state except California and Oklahoma (which also experienced severe oversupply crises).

2024-2025: Market Contraction Begins

The market correction accelerated in 2024. Wholesale prices fell below $1,000 per pound for premium flower in the first quarter and continued declining throughout the year. By December 2024, average wholesale prices ranged from $600 to $800 per pound, with some bulk transactions occurring below $500 per pound. Facility closures began in earnest. According to MRA data, 147 licenses were surrendered or revoked in 2024, the highest annual total since the adult-use program launched. Closures concentrated among standalone cultivators and smaller processors unable to achieve economies of scale. Employment data reflected the contraction. The Michigan Cannabis Industry Association estimated that direct cannabis employment peaked at approximately 28,000 jobs in mid-2023 and declined to 25,000 by early 2025, with further reductions anticipated. Despite the glut, the MRA continued accepting new applications under the MRTMA's statutory framework, which does not authorize supply-based license caps. By April 2025, active licenses had declined to 1,389 as closures outpaced new issuances, but the state still had more cultivation capacity than consumer demand could absorb at profitable price points.

2026: Crisis Deepens

The May 2026 announcement of the Lansing facility closure and 95-worker layoff underscored the crisis's severity. Wholesale prices had fallen to $400 to $600 per pound, levels at which most cultivation operations cannot cover costs including labor, utilities, compliance, and taxation. Industry representatives have called for regulatory relief, including reducing license fees, streamlining compliance requirements, and addressing the federal tax burden under Internal Revenue Code Section 280E, which prohibits cannabis businesses from deducting ordinary business expenses. However, these federal restrictions remain beyond state control, and Michigan lawmakers have shown limited appetite for reducing state tax rates or fees that fund regulatory operations and municipal revenue sharing.

Key Players in Michigan's Cannabis Market Crisis

Michigan Cannabis Regulatory Agency (MRA)

The MRA, operating within the Department of Licensing and Regulatory Affairs, administers both the MMFLA and MRTMA. The agency issues licenses, conducts inspections, enforces compliance, and maintains the statewide monitoring system (Metrc) that tracks cannabis from seed to sale. Brian Hanna has served as executive director since 2021. The MRA has defended its licensing approach, noting that the MRTMA does not authorize supply-based caps and that the agency's mandate is to implement the voter-approved law, not to manage market economics. In public statements, MRA officials have emphasized that Michigan's regulatory framework prioritizes consumer safety and market access over protecting incumbent operators from competition.

Michigan Cannabis Industry Association (MCIA)

The MCIA represents licensed operators across the supply chain. The trade group has advocated for regulatory relief, including reducing the state's $10,000 annual license renewal fees for growers and processors, streamlining testing requirements, and increasing enforcement against unlicensed operators. Robin Schneider serves as executive director. In testimony before the Michigan Legislature in March 2026, Schneider said the industry faces an "existential crisis" driven by oversupply and that without intervention, Michigan risks losing the small and mid-sized operators that provide market diversity and employment in communities across the state.

Multi-State Operators (MSOs)

Large MSOs including Cresco Labs, Green Thumb Industries, Verano Holdings, and Skymint (a Michigan-based regional operator) have weathered the downturn better than smaller competitors due to vertical integration, economies of scale, and access to capital. However, even MSOs have closed underperforming facilities and reduced cultivation footprints. Cresco Labs announced in February 2026 that it would consolidate Michigan cultivation into a single facility and close two smaller grow operations, eliminating approximately 60 positions. The company cited wholesale price compression and the need to optimize operations for profitability.

Municipal Governments

Cities including Detroit, Lansing, Ann Arbor, and Traverse City have become stakeholders in the market's health due to reliance on cannabis tax revenue. Detroit imposes a local excise tax generating approximately $10 million annually, funding road repairs and public safety initiatives. As facilities close, municipalities face both revenue loss and the challenge of vacant industrial properties purpose-built for cannabis cultivation. Some cities have begun exploring zoning changes to allow former grow facilities to convert to other uses, but the specialized infrastructure (high-power electrical systems, HVAC, security) limits alternative applications.

Social Equity Applicants

Michigan's social equity program, established under the MRTMA, provides fee reductions and technical assistance to applicants from communities disproportionately impacted by cannabis prohibition. However, the program has struggled to achieve its goals amid market contraction. According to MRA data, social equity applicants hold approximately 11% of active licenses as of April 2026. Many social equity operators entered the market in 2021-2022, securing licenses just as wholesale prices began collapsing. Without access to the capital reserves that sustain larger operators through downturns, social equity businesses face disproportionate closure risk.

Legal and Regulatory Framework

Michigan's cannabis market operates under a dual-statute framework that creates both medical and adult-use pathways, each with distinct licensing structures, tax treatments, and regulatory requirements. The Medical Marihuana Facilities Licensing Act (MMFLA), MCL 333.27101 et seq., governs medical cannabis commerce. The Michigan Regulation and Taxation of Marihuana Act (MRTMA), MCL 333.27951 et seq., governs adult-use commerce. Operators may hold licenses under both statutes, and many facilities serve both medical patients and adult-use customers. Both statutes preserve municipal opt-in authority under MCL 333.27956 (MRTMA) and MCL 333.27205 (MMFLA). Municipalities may prohibit cannabis facilities entirely, limit the number or type of licenses, impose additional operating requirements, and charge local licensing fees. As of April 2026, approximately 62% of Michigan's 1,773 cities and townships had opted in to allow some form of cannabis commerce, though many impose restrictive zoning or cap license numbers. License types under the MRTMA include:

• Class A Grower (up to 100 plants): $4,000 application fee, $20,000 annual regulatory fee
• Class B Grower (up to 500 plants): $8,000 application fee, $30,000 annual regulatory fee
• Class C Grower (up to 2,000 plants): $40,000 application fee, $40,000 annual regulatory fee
• Processor: $4,000 application fee, $20,000 annual regulatory fee
• Retailer: $5,000 application fee, $25,000 annual regulatory fee
• Secure Transporter: $1,000 application fee, $10,000 annual regulatory fee
• Safety Compliance Facility: $5,000 application fee, $25,000 annual regulatory fee

The MRTMA imposes a 10% excise tax on retail sales, collected at the point of sale and remitted to the state. Combined with Michigan's 6% sales tax, consumers pay 16% in state taxes on adult-use purchases. Medical patients with valid registry cards are exempt from the excise tax and sales tax. Revenue from the excise tax is distributed according to MCL 333.27964: first to MRA implementation costs, then 15% to municipalities with retail facilities, 15% to counties with retail facilities, 35% to the School Aid Fund, and 35% to the Michigan Transportation Fund. Federal law remains a critical constraint. Cannabis remains a Schedule I controlled substance under the Controlled Substances Act, 21 U.S.C. § 812. Internal Revenue Code Section 280E prohibits businesses trafficking in Schedule I or II substances from deducting ordinary business expenses for federal tax purposes, leaving only cost of goods sold (COGS) as deductible. This creates effective federal tax rates of 60% to 80% of gross profit for cannabis operators, a burden that becomes unsustainable when wholesale prices collapse. Banking access remains limited due to federal prohibition. While the Financial Crimes Enforcement Network (FinCEN) issued guidance in 2014 allowing banks to serve cannabis businesses under certain conditions, most national banks decline cannabis accounts due to federal illegality. Michigan operators rely on a small number of state-chartered credit unions and cannabis-focused financial services providers, paying premium fees for basic banking services.

State-by-State Context: How Michigan Compares

Michigan's oversupply crisis mirrors similar dynamics in other states that adopted unlimited or high-cap licensing models, while contrasting sharply with limited-license markets that maintained price stability through supply constraints.

Oklahoma

Oklahoma represents the most extreme case of oversupply. The state issued over 9,000 cultivation licenses between 2018 and 2022 under a medical program with minimal barriers to entry. Wholesale prices collapsed to under $100 per pound by 2022, forcing mass closures. By 2024, Oklahoma had fewer than 3,000 active licenses, down from a peak of 12,000. Michigan's trajectory resembles Oklahoma's, though Michigan's larger population and tourist economy provide somewhat more demand support.

California

California, the nation's largest cannabis market, has also experienced oversupply and price compression, with wholesale prices falling from $1,500 per pound in 2018 to $500 to $800 per pound in 2025. However, California's crisis stems partly from competition with a massive illicit market, estimated at 60% to 75% of total consumption. Michigan's illicit market is smaller, estimated at 30% to 40% of consumption, making oversupply the primary driver of price collapse.

Illinois

Illinois adopted a limited-license model, issuing approximately 180 adult-use licenses through competitive scoring processes that prioritized social equity and geographic diversity. Wholesale prices in Illinois have remained above $2,000 per pound through 2025, and operators report sustained profitability. However, Illinois has faced criticism for high retail prices (often $60 to $80 per eighth-ounce) and limited consumer access, particularly in rural areas.

Massachusetts

Massachusetts implemented moderate licensing constraints, requiring municipalities to opt in and imposing host community agreements that limit facility numbers. The state had approximately 400 active licenses as of 2025, and wholesale prices have stabilized around $1,200 to $1,600 per pound. Massachusetts represents a middle path between Michigan's unlimited approach and Illinois's strict caps.

Ohio

Ohio launched adult-use sales in August 2024 under a framework that converted existing medical licenses and added new adult-use licenses through a competitive process. The state capped total licenses at approximately 350 for the first two years. Early data suggests wholesale prices have remained stable around $1,800 to $2,200 per pound, though the market remains too young for definitive conclusions.

Market and Business Implications

The Michigan market contraction is reshaping the state's cannabis industry through consolidation, vertical integration, and a flight to quality that favors well-capitalized operators over small independents. Wholesale price data from the MRA's Metrc tracking system shows the collapse's severity. In January 2022, the average wholesale price for flower was $2,247 per pound. By January 2024, it had fallen to $823 per pound. By April 2026, average wholesale prices ranged from $412 per pound for outdoor-grown flower to $627 per pound for premium indoor flower. At these price points, cultivation economics become unsustainable for most operators. Industry analysts estimate that all-in production costs (including labor, utilities, rent, compliance, testing, and taxes) range from $600 to $900 per pound for efficient indoor operations and $300 to $500 per pound for greenhouse operations. With wholesale prices at or below production costs, only the most efficient operators with paid-off infrastructure can maintain positive cash flow. The crisis has accelerated consolidation. MSOs and well-capitalized regional operators are acquiring distressed assets at steep discounts. In March 2026, Green Thumb Industries acquired a 200,000-square-foot cultivation facility in Battle Creek for $8.2 million, approximately 30% of the facility's construction cost. Such acquisitions allow large operators to expand capacity at minimal capital expenditure while eliminating competitors. Vertical integration has become essential for survival. Operators that control cultivation, processing, and retail can capture margin at each stage and ensure outlet for their production. Standalone cultivators without retail operations face the worst economics, forced to sell into a wholesale market where buyers have pricing power. The concentrate and edibles segments have provided some margin relief. Wholesale prices for distillate and other concentrate inputs have fallen less dramatically than flower prices, declining from approximately $8 to $12 per gram in 2022 to $4 to $7 per gram in 2026. Processors that can convert low-cost flower into higher-margin products maintain better economics than flower-only operations. Retail has proven most resilient. While retailer margins have compressed due to competitive pressure, dispensaries benefit from the 10% excise tax being calculated on retail price rather than wholesale cost, allowing them to maintain percentage margins even as absolute dollar margins decline. However, retail consolidation is also occurring, with approximately 40 dispensaries closing in 2024-2025 as operators rationalize store counts. Capital markets have largely closed to Michigan cannabis operators. Equity raises that were routine in 2020-2021 became scarce by 2023, and debt financing carries prohibitive interest rates (often 12% to 18%) due to federal illegality and market distress. Operators unable to self-fund through cash flow face difficult choices: raise capital at punitive valuations, sell to larger competitors, or close. Employment impacts extend beyond direct job losses. Ancillary businesses including security providers, HVAC contractors, lighting suppliers, and packaging manufacturers have seen revenue decline as operators reduce spending. The ripple effects touch communities across Michigan that developed cannabis-dependent economic clusters.

What Experts Say

Industry analysts, economists, and policy experts attribute Michigan's crisis to predictable market dynamics that state regulators and lawmakers failed to address despite clear warning signs from other states. According to Beau Whitney, senior economist at Whitney Economics, a cannabis market research firm, Michigan's experience demonstrates the dangers of treating cannabis like a typical agricultural commodity without accounting for federal prohibition's constraints. In a March 2026 analysis, Whitney noted that unlimited licensing combined with 280E taxation creates a "perfect storm" where operators cannot deduct losses to offset tax liability, accelerating business failures during downturns. Andrew Brisbo, former executive director of the MRA who departed in 2023, defended the agency's approach in a 2024 interview with MJBizDaily, stating that the MRTMA's statutory language required the agency to issue licenses to qualified applicants and that imposing supply caps would have required legislative action. Brisbo noted that the voter-approved initiative prioritized market access and that restricting licenses to protect incumbent operators would have contradicted the law's intent. Robin Schneider of the Michigan Cannabis Industry Association has called for a multi-pronged response including reducing state regulatory fees, increasing enforcement against unlicensed operators, and exploring tax restructuring to reduce the burden on distressed operators. In March 2026 legislative testimony, Schneider said that without intervention, Michigan risks losing the market diversity that makes the industry resilient and innovative. Rick Thompson, a cannabis attorney and longtime reform advocate in Michigan, has argued that the crisis stems from the state's failure to learn from Oklahoma's experience. In a February 2026 op-ed in the Detroit Free Press, Thompson wrote that Michigan had two years of warning as Oklahoma's market collapsed but took no action to prevent the same dynamics from unfolding in Michigan. Shaleen Title, a cannabis policy expert and former Massachusetts Cannabis Control Commissioner, has pointed to Michigan as evidence that unlimited licensing without demand analysis creates equity harms. In a April 2026 interview, Title noted that social equity operators who entered Michigan's market in 2021-2022 faced immediate disadvantage competing against established operators in a collapsing market, undermining the equity program's goals.

What's Next: Scenarios and Decision Points

Michigan's cannabis market faces a multi-year adjustment period with several possible trajectories depending on regulatory responses, federal policy changes, and market consolidation dynamics. The most likely near-term scenario involves continued consolidation and capacity reduction. Industry analysts project that Michigan will stabilize with 800 to 1,000 active licenses, down from the current 1,437, with closures concentrated among standalone cultivators and smaller processors. This consolidation could take 18 to 36 months as operators exhaust capital reserves and lenders foreclose on distressed assets. Wholesale prices are expected to stabilize in the $600 to $900 per pound range for premium flower, a level that allows efficient vertically integrated operators to maintain profitability while forcing marginal producers to exit. This stabilization depends on capacity reduction outpacing any demand growth from population increases or tourism. Legislative intervention remains possible but uncertain. Bills introduced in the Michigan Legislature in early 2026 would reduce annual regulatory fees by 50% for growers and processors, potentially saving operators $10,000 to $20,000 annually. However, these bills face opposition from lawmakers concerned about replacing the lost revenue, which funds MRA operations. The Legislature's 2026-2027 session will determine whether fee relief advances. Federal rescheduling of cannabis could provide significant relief. If the Drug Enforcement Administration moves cannabis from Schedule I to Schedule III under the Controlled Substances Act—a process that has been under consideration since 2023—cannabis businesses would become eligible for normal tax deductions under 280E. This change could reduce effective tax rates from 60% to 80% of gross profit to 25% to 35%, improving economics across the supply chain. However, rescheduling timelines remain uncertain, with administrative and legal challenges potentially delaying implementation into 2027 or beyond. Interstate commerce represents a longer-term wildcard. If federal law changes to permit interstate cannabis commerce, Michigan's low production costs could position the state as a major exporter to higher-price markets in the Northeast and Mid-Atlantic. However, interstate commerce would also expose Michigan to competition from even lower-cost producers in California and Oregon, potentially driving further price compression. The illicit market's trajectory will influence legal market recovery. Michigan has increased enforcement against unlicensed operators, with the MRA conducting 347 inspections of suspected unlicensed facilities in 2025, up from 189 in 2024. Sustained enforcement could shift consumer spending from illicit to legal channels, supporting demand for licensed operators. However, enforcement requires resources, and budget constraints may limit the MRA's capacity to scale efforts. Key dates and milestones to monitor include:

• June 2026: Michigan Legislature's summer session concludes; regulatory fee reduction bills must advance or die
• September 2026: MRA releases Q2 2026 market data, providing clarity on closure pace and price trends
• December 2026: Federal rescheduling administrative process potentially concludes (timeline uncertain)
• March 2027: Michigan fiscal year 2028 budget process begins; cannabis tax revenue projections will inform state spending
• November 2027: Municipal elections in many Michigan cities; cannabis policy may become local campaign issue

Further Reading and Primary Sources

• Michigan Regulation and Taxation of Marihuana Act (MRTMA), MCL 333.27951 et seq. — https://legislature.mi.gov/documents/mcl/pdf/mcl-act-281-of-2018.pdf
• Michigan Medical Marihuana Facilities Licensing Act (MMFLA), MCL 333.27101 et seq. — https://legislature.mi.gov/documents/mcl/pdf/mcl-act-281-of-2016.pdf
• Michigan Cannabis Regulatory Agency official data portal — https://www.michigan.gov/cra
• Michigan Cannabis Regulatory Agency monthly market reports and license data — https://www.michigan.gov/cra/resources/data
• Internal Revenue Code Section 280E, 26 U.S.C. § 280E — https://www.law.cornell.edu/uscode/text/26/280E
• Controlled Substances Act, 21 U.S.C. § 812 (scheduling provisions) — https://www.law.cornell.edu/uscode/text/21/812
• Michigan Cannabis Industry Association policy positions and market analysis — https://www.michigancannabisindustry.org
• Whitney Economics Michigan market reports and wholesale price tracking — https://www.whitneyeconomics.com
• Viridian Capital Advisors cannabis investment and M&A data — https://www.viridianca.com
• Metrc Michigan tracking system (license holder access) — https://mi.metrc.com